This report analyzes the worldwide markets for Parenteral Nutrition in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 20 companies including many key and niche players such as -

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Table 35: Diabetes Statistics in the US (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) (includes corresponding Graph/Chart)

Parenteral Nutrition – Vital for Preterm Infants

Table 36: Preterm Birth Rate (%) in the US by State for 2015

Table 37: Preterm Birth Rate (%) in the US by Race/Ethnicity for 2014 and 2015 (includes corresponding Graph/Chart)

Table 38: Preterm Birth Rate (%) in the US by Gestational Age for 2014 and 2015 (includes corresponding Graph/Chart)

Table 49: Canadian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 50: Canadian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

3. JAPAN

A. Market Analysis

Outlook

Rising Cancer and Diabetes Cases Provide Growth Opportunity

Table 51: Cancer Incidence and Number of Cancer-Related Deaths among Japanese Men and Women for 2015 (includes corresponding Graph/Chart)

Table 53: Japanese Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 54: Japanese Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 63: French Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 64: French Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4b. GERMANY

A. Market Analysis

Outlook

Select Players

B. Market Analytics

Table 65: German Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 66: German Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4c. ITALY

Market Analysis

Table 67: Italian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 68: Italian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

A. Market Analysis

Outlook

Product Launch

B. Market Analytics

Table 69: UK Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 70: UK Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4e. SPAIN

A. Market Analysis

Outlook

Grifols International S.A. – A Key Player

B. Market Analytics

Table 71: Spanish Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 72: Spanish Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4f. RUSSIA

Market Analysis

Table 73: Russian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 74: Russian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

A. Market Analysis

Outlook

Allergan plc (Ireland) – A Key Player

B. Market Analytics

Table 75: Rest of European Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 76: Rest of European Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 84: Australian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 85: Australian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

5b. CHINA

A. Market Analysis

Outlook

Select Players

B. Market Analytics

Table 86: Chinese Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 87: Chinese Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

5c. INDIA

A. Market Analysis

Outlook

Strategic Corporate Developments

Amanta Healthcare Ltd – A Key Player

B. Market Analytics

Table 88: Indian Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 89: Indian Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

5d. REST OF ASIA-PACIFIC

A. Market Analysis

Outlook

Strategic Corporate Development

B. Market Analytics

Table 90: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 91: Rest of Asia-Pacific Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA

A. Market Analysis

Increasing Incidence of Chronic Conditions: Opportunity for PN Market

Diabetes Prevalence Statistics

Table 92: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart)

Table 93: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Number of Adults with Undiagnosed Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart)

Table 96: Middle East & Africa Recent Past, Current and Future Analysis for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 97: Middle East & Africa Historic Review for Parenteral Nutrition Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 99: Latin American Recent Past, Current and Future Analysis for Parenteral Nutrition by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 100: Latin American Historic Review for Parenteral Nutrition by Geographic Region - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for the Years 2011 through 2015 (includes corresponding Graph/Chart)